10.1371/journal.pone.0012226 30
You should definitely get my Birth Control Protocol to learn more about how to support yourself as you transition off the pill
Peptide aggregation has not been assessed in human studies
Blocked blood vessels not in the heart or brain
Most incretin-based therapies drive impressive fat loss, but at a cost: significant lean mass depletion worse metabolic health higher long-term risk, especially in Diabetes This graphic highlights a two-pronged approach: Semaglutide reduces appetite & fat mass Bimagrumab blocks ActRIIA/B signalling, preventing muscle atrophy Clinical data (BELIEVE trial) shows that combining the two: enhances fat loss preserves or increases lean mass improves overall body composition, not just the number on the scale In a season where weight gain is almost guaranteed, the future of obesity treatment isnt eat less and lose everything. Its lose fat while building muscle
As costs rise and demand grows, many organizations are unsure how to balance access, equity, and sustainability
